Conversely, a significant reduction in EpCAM expression was noted in colon adenocarcinoma (COAD), glioblastoma multiforme (GBM), as well as in liver hepatocellular carcinoma (LIHC) and renal cancer (Fig. 2A). The gene discussed is EPCAM; the disease is glioblastoma.